Want to see NBIX full AI Analyst Report?
Neurocrine (NBIX) Drug Pipeline
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Neurocrine Biosciences (NBIX) have in its pipeline
Neurocrine NBIX is currently developing the following drugs: Nbi-1065890, Nbi-1117570, Nbi-1117568, Nbi-1065845, Crinecerfont, Valbenazine, Nbi-1070770, Nbi-921352, Nbi-827104, Luvadaxistat, Nbi-1065846, Tak-831 Oral Tablet, [14C]Tak-831 Iv Infusion, [14C]Tak-831 Oral Suspension, Tak-653, Ketamine, Nbi-98854, Tak-831 T2, Tak-831 T3. These drug candidates are in various stages of clinical development as the company works toward FDA approval.